• Molecular NamePrazepam
  • SynonymPrazepamum [inn-latin]
  • Weight324.811
  • Drugbank_IDDB01588
  • ACS_NO2955-38-6
  • Show 2D model
  • LogP (experiment)3.73
  • LogP (predicted, AB/LogP v2.0)3.84
  • pka2.7
  • LogD (pH=7, predicted)3.84
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-5.06
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds3
  • TPSA32.67
  • StatusFDA approved; US withdrawn
  • AdministrationN/A
  • PharmacologyA benzodiazepine derivative drug. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding97.0
  • Volume of distribution (VD)Desmethyldiazepam, 0.5 to 2.5 L/kg, increased in elderly subjects.
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half lifedesmethyldiazepam about 40~100 h but there is considerable intersubject variation—see under Nordazepam.
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A